GBA1 and Parkinson disease: Related to this, inhibition of GCase activity in differentiated SH-SY5Y cells [84] or GBA1 depletion/mutation in dopaminergic neurons differentiated from human PD-iPSCs with a heterozygous GBA1 mutation (N370S/WT) led to accumulation of αS monomers [85].